Healthcare shares were fairly flat in pre-market trade on
In healthcare stocks news, GW Pharmaceuticals (
) shares were up 6% pre-market after the company said preliminary
data from a trial into its Epidiolex treatment for drug-resistant
epilepsy showed positive results.
The company released physician reports of efficacy and safety
data on 27 children and young adults with treatment-resistant
epilepsy who have been treated with GW's investigational
) product candidate for a period of 12 weeks.
And, Galena Biopharma, Inc. (
), a biopharmaceutical company developing and commercializing
oncology treatments, completed the enrollment in the company's
Phase 2a clinical trial for a ovarian and endometrial cancer
GALE was up about 7% pre-market.
Finally, Isis Pharmaceuticals (
) says it has earned a $10 million milestone payment from Biogen
) associated with the validation of an undisclosed target to treat
a neurological disorder. This is the first milestone payment under
their 2013 strategic collaboration to advance the treatment of
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.